Lantheus Holdings (LNTH - Free Report) isn't
exactly a household name. In fact, I am betting that this stock is
flying well under the radar for most investors. There are a few
things that stick out to me for this play as a good long term
investment and there are a few that are more short term in nature.
Either way you cut it LNTH is looking good to me.
First let me list the positives I see with this stock and then we
can go over the normal attributes that have made this Zacks Rank #1
(Strong Buy) stock the Bull of the Day.
Why I Like It
This is a small cap stock in a "risk on" environment.
Small cap stocks have been out-performing of late.
Revenue trends are pointing to continued sequential growth.
5 straight beats of the Zacks Consensus Estimate.
Room for multiple expansion (trades at 14x forward earnings as
compared to 22x industry average).
Follow Brian Bolan on twitter at
@BBolan1 and on StockTwits at the same address.
The Recent Numbers
LNTH beat the Zacks Consensus Estimate of
$0.06 when it reported $0.24 in the first week of August. This
$0.18 beat was
good for a 300% positive earnings surprise.
The topline was also impressive with the company
delivering $78M in sales when the Zacks Consensus Estimate was
looking for $73M. That $5M beat was good for a 7.25% positive
I mentioned the idea of sequential revenue growth as one of the
reasons I like this stock. Last year the company recorded revenues
of $75M in the March quarter and then posted $73M in the June
quarter. That isn't what gets me excited and isn't growth, it is
contraction. This year the March quarter saw $76M while the June
quarter was $78M. So where there was contraction last year, this
year we have expansion.
LNTH is in the medical products industry and they sell
products in the diagnostic imaging space. Roughly half the sales
come from DEFINITY which helps doctors when looking at
echocardiograms. The basic idea is the aging population is going
to the doctors office a lot more and this helps identify problems,
or rather, show that there arent health problems (hopefully).
As you can see from the image above, DEFINITY helps physicians interpret echo-cardiograms.
I have already mentioned the fact that LNTH has beaten the
Zacks Consensus Estimate in each of the five reports that I see.
What I didn't mention what that they are HUGE beats. The first
beat was 135% ahead of expectations and it was followed up by a 350%
The December 2015 quarter saw the company post EPS of $0.13 when
the Zacks Consensus Estimate was calling for a break-even quarter.
That sort of beat tends to get investor's attention and as a result
they bid the stock higher by more than 17% in the session following
the earnings release.
The topline also has a very strong history, but there isn't
a lot of data yet. That said, let's take a look at this chart that
shows just the quarterly revenues.
There was a recent big move higher in estimates. The Zacks
Consensus Estimate was holding at $0.32 over the last three months,
but in August the number has shot up to $0.54.
The 2017 number also saw a big move higher, with the estimate going
from $0.61 to $0.73. This tells me things are moving in the right
Here is a chart of the trailing twelve months EPS:
I mentioned the forward PE as being very attractive, but I need to
also mention the price to sales multiple. It comes in at 0.8x
while the industry average is a healthy 3.1x. This implies the
stock is trading at a big discount.
I see the analyst are looking at earnings contraction this year,
but next year we are looking at earnings growth of 36%. Couple
that with revenue growth that is ahead of the industry average and
you have something really great on your hands.
Zacks has developed a chart that helps investors see
how earnings estimates have impacted the price of the stock
over the last several years. We call this chart the price and
consensus chart, and each color coded lines represents analyst
estimates over a designated year. As estimates increase, the
stock tends to follow. The Zacks Rank is impacted by earnings
estimate increases, beats and incorporates the idea of analyst
agreement and magnitude. As a Zacks Rank #1 (Strong Buy) we see
that estimates are moving higher.
Confidential from Zacks
Beyond this Bull of the Day, would you like to see
Zacks' best recommendations that are not available to the public?
Our Executive VP, Steve Reitmeister, knows when key trades are
about to be triggered and which of our experts has the hottest
hand. Click to see them now >>.
Follow Brian Bolan on twitter at